Kopion Asset Management LLC grew its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 22.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 156,401 shares of the technology company's stock after buying an additional 28,980 shares during the quarter. Simulations Plus makes up 1.8% of Kopion Asset Management LLC's portfolio, making the stock its 19th largest position. Kopion Asset Management LLC owned about 0.78% of Simulations Plus worth $2,729,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SLP. Conestoga Capital Advisors LLC lifted its position in Simulations Plus by 17.2% during the 1st quarter. Conestoga Capital Advisors LLC now owns 2,609,388 shares of the technology company's stock worth $63,982,000 after buying an additional 383,126 shares in the last quarter. Wellington Management Group LLP bought a new position in shares of Simulations Plus in the 1st quarter valued at about $2,458,000. Uniplan Investment Counsel Inc. grew its position in shares of Simulations Plus by 141.8% in the 1st quarter. Uniplan Investment Counsel Inc. now owns 144,202 shares of the technology company's stock valued at $3,536,000 after acquiring an additional 84,562 shares during the period. Stephens Inc. AR grew its position in shares of Simulations Plus by 191.1% in the 1st quarter. Stephens Inc. AR now owns 94,439 shares of the technology company's stock valued at $2,316,000 after acquiring an additional 61,992 shares during the period. Finally, North Star Investment Management Corp. bought a new position in shares of Simulations Plus in the 1st quarter valued at about $1,300,000. 78.08% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on SLP shares. JMP Securities reissued a "market perform" rating on shares of Simulations Plus in a research report on Wednesday, June 18th. Stephens dropped their price objective on shares of Simulations Plus from $28.00 to $20.00 and set an "overweight" rating on the stock in a research report on Tuesday, July 15th. KeyCorp lowered shares of Simulations Plus from an "overweight" rating to a "sector weight" rating in a research report on Tuesday, July 15th. William Blair reissued an "outperform" rating on shares of Simulations Plus in a research report on Tuesday, July 15th. Finally, Craig Hallum dropped their price objective on shares of Simulations Plus from $45.00 to $36.00 and set a "buy" rating on the stock in a research report on Friday, June 13th. Four research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $26.50.
View Our Latest Research Report on Simulations Plus
Simulations Plus Price Performance
SLP stock traded down $0.24 during midday trading on Friday, reaching $15.62. 175,765 shares of the stock were exchanged, compared to its average volume of 434,988. The stock has a market capitalization of $314.43 million, a PE ratio of -4.96 and a beta of 0.85. Simulations Plus, Inc. has a 52 week low of $12.39 and a 52 week high of $37.67. The company has a fifty day moving average price of $14.02 and a 200 day moving average price of $22.33.
Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings data on Monday, July 14th. The technology company reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.19. The business had revenue of $20.36 million for the quarter, compared to analyst estimates of $22.83 million. Simulations Plus had a positive return on equity of 11.62% and a negative net margin of 78.63%.Simulations Plus's quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.27 EPS. As a group, analysts anticipate that Simulations Plus, Inc. will post 1.09 earnings per share for the current fiscal year.
About Simulations Plus
(
Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Stories

Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.